A Mitacs intern and master’s student has helped Moncton-based Picomole harness the power of AI to make a major breakthrough in combining machine learning and breath analysis, which is considered a game changer in healthcare.

With the support of Dalhousie University students, a Nova Scotia-based start-up is developing a first-of-its-kind smart coating for ships. The company has recently won a Mitacs Entrepreneur Award for its innovation.

For several start-ups that are resident at JLABS @ Toronto, not even COVID-19 has paused their plans to recruit talent and scale up; they counted on Mitacs’s programs to help set their businesses up for potential success.

Montréal-based small business launches a smartwatch that measures the blood oxygen level, body temperature, and heart rate, enabling early detection of COVID-19 symptoms and support for seniors in residences.

Entrepreneur and former Mitacs intern Andrée-Ann Adam’s invention prevents gum disease, improving the health of pets’ teeth. Now her small business is on a trajectory for success thanks to increasing demand.

A Globalink Research Internship leads to graduate studies in Canada for the founder of NuPort Robotics, the country’s first autonomous trucking company that uses eco-friendly, self-driving electric trucks for short-haul drives.

In the turbulent COVID-19 context, Humanitas Solutions has adapted technologies it developed after the 2010 earthquake in Haiti to help the health system counter the effects of the pandemic. Mitacs interns from five universities are helping to implement solutions to deal with the emerging second wave.

Working towards a COVID-19 vaccine, Selvaraj and Kaliamurthi use artificial intelligence and reverse vaccinology.

In many remote locations, access to medical supplies, which can make the difference between a speedy recovery and death, can be limited because of their sensitivity to temperature variations during transport.

One company that’s addressing the need for a vaccine is Medicago, a biopharmaceutical company that’s using a new manufacturing technology based on Plants and Virus-like Particles (VLP). Medicago is creating a vaccine that has the potential to promote antibody production, and unlike cell culture systems, plant systems do not require complicated growth or storage conditions.

Research abroad results in development of special virus-killing coating for masks

‘Buddy’ is no friend to maple syrup producers, costing the industry millions of dollars each year across eastern North America.